glp-1 for iih The effect of agonist on idiopathic intracranial hypertension: a systematic review and meta-analysis The effect of GLP-1 agonist
Description
Am J Physiol 310:F738F743
In subjects with T2DM, weekly administration of tirzepatide at doses of 5 mg, 10 mg, or 15 mg was associated with greater weight loss compared to placebo ( 6.3 kg, 8.4 kg, and 9.4 kg, respectively), and 1.7 kg, 4.8 kg, and 7.2 kg greater weight loss compared to selective GLP-1 receptor agonists, demonstrating a dose-dependent effect sustained for up to 2 years [48]
An oral GLP1 and GIP dual receptor agonist improves metabolic disorders in high fat-fed mice
Our team is committed to supporting you every step of the way to ensure your treatment is as comfortable and effective as possible
doi: 10.1177/014107680609900220
